Business Context and Reporting Period
This Form 6-K is filed by Innate Pharma S.A., a foreign private issuer headquartered in Marseille, France. The report covers the month of May 2021, with the specific filing date of May 11, 2021. The document serves to incorporate by reference a press release (Exhibit 99.1) into the company's registration statement on Form F-3.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts solely as a conduit for the referenced press release.
Material Changes
The filing text does not provide details on material changes versus prior periods. Any significant updates or changes are contained within the incorporated press release (Exhibit 99.1), the content of which is not included in the input text.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, and contingencies are not detailed in the Form 6-K cover page. These elements are presumed to be addressed in the referenced press release dated May 11, 2021.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 11, 2021) for the specific corporate announcement triggering this filing.
- Verify the incorporation by reference into Form F-3 (File No. 333-252074) for potential impacts on capital raising activities.
- Confirm that no other financial statements or operational updates were attached to this specific Form 6-K submission.